We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70
Avg Time Held
12 quarters
Top 10 Avg Time Held
12 quarters
Top 20 Avg Time Held
10.4 quarters

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BHVN icon
1326
Biohaven
BHVN
$1.78B
– –
-4,150
Closed -$227K –
BL icon
1327
BlackLine
BL
$1.7B
– –
-3,456
Closed -$223K –
CABO icon
1328
Cable One
CABO
$65.5M
– –
-726
Closed -$307K –
CIM icon
1329
Chimera Investment
CIM
$733M
– –
-4,657
Closed -$64.4K –
CVCO icon
1330
Cavco Industries
CVCO
$4.05B
– –
-510
Closed -$204K –
DNA icon
1331
Ginkgo Bioworks
DNA
$794M
– –
-1,913
Closed -$88.8K –
DRVN icon
1332
Driven Brands
DRVN
$1.94B
– –
-10,327
Closed -$163K –
EVH icon
1333
Evolent Health
EVH
$481M
– –
-6,807
Closed -$223K –
FHI icon
1334
Federated Hermes
FHI
$4.18B
– –
-6,757
Closed -$244K –
FOXF icon
1335
Fox Factory Holding Corp
FOXF
$757M
– –
-6,095
Closed -$317K –
GEF icon
1336
Greif
GEF
$4.47B
– –
-3,613
Closed -$249K –
GEVO icon
1337
Gevo
GEVO
$316M
– –
-13,202
Closed -$10.1K –
GO icon
1338
Grocery Outlet
GO
$1.18B
– –
-11,609
Closed -$334K –
HI icon
1339
DELISTED
Hillenbrand
HI
– –
-4,272
Closed -$215K –
HTZ icon
1340
Hertz
HTZ
$659M
– –
-15,909
Closed -$125K –
IART icon
1341
Integra LifeSciences
IART
$1.09B
– –
-8,093
Closed -$287K –
ICLR icon
1342
Icon
ICLR
$12.7B
– –
-4,123
Closed -$1.39M –
IRWD icon
1343
Ironwood Pharmaceuticals
IRWD
$621M
– –
-14,229
Closed -$124K –
KSS icon
1344
Kohl's
KSS
$2.4B
– –
-8,921
Closed -$260K –
LEG icon
1345
DELISTED
Leggett & Platt
LEG
– –
-15,904
Closed -$305K –
LNC icon
1346
Lincoln National
LNC
$7.75B
– –
-8,037
Closed -$257K –
LPL icon
1347
LG Display
LPL
$2.75B
– –
-10,191
Closed -$41.8K –
MDXG icon
1348
MiMedx Group
MDXG
$705M
– –
-15,337
Closed -$118K –
MRVI icon
1349
Maravai LifeSciences
MRVI
$1.05B
– –
-10,297
Closed -$89.3K –
MVST icon
1350
Microvast
MVST
$212M
– –
-11,896
Closed -$9.96K –
52 53
54
55 56

Similar funds

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.